Back to Directory
AmnioCam
Founded 2025
Stem-cell-derived amniotic cells for wound healing
AmnioCam is a regenerative medicine company developing human amniotic epithelial cells for wound care and research. Its technology originated at the Babraham Institute and uses human pluripotent stem cells to produce these cells. The team aims to reduce reliance on donated placentas and the variability between donors. It has studied the cells in human skin models to assess their potential for tissue repair.